Patents by Inventor Joanne L. Viney

Joanne L. Viney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BTNL9 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF
    Publication number: 20130101590
    Abstract: The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.
    Type: Application
    Filed: April 8, 2011
    Publication date: April 25, 2013
    Inventors: Heather A. Arnett, Sabine S. Escobar, Ryan M. Swanson, Joanne L. Viney
  • METHODS OF USING BTL-II PROTEINS
    Publication number: 20120258097
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Application
    Filed: April 10, 2012
    Publication date: October 11, 2012
    Applicant: Immunex Corporation
    Inventors: Peter R. BAUM, Sabine S. Escobar, Joanne L. Viney
  • Methods of using BTL-II proteins
    Patent number: 8173603
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: May 8, 2012
    Assignee: Immunex Corporation
    Inventors: Peter R. Baum, Sabine S. Escobar, Joanne L. Viney
  • CALCIMIMETIC COMPOUND FOR USE IN THE TREATMENT OF EPITHELIAL INJURY
    Publication number: 20110144102
    Abstract: This invention relates generally to the field of medicine and, more specifically, to methods for treating epithelial injury, in particular, due to ischemia, hypoxia, trauma, chemolytics or radiation exposure.
    Type: Application
    Filed: March 27, 2009
    Publication date: June 16, 2011
    Inventors: John Peter Geibel, Steven Charles Hebert, Patricia R. Hebert, David Martin, Gordon Ng, William G. Richards, Joanne L. Viney
  • METHODS OF USING BTL-II PROTEINS
    Publication number: 20100330104
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Application
    Filed: March 3, 2010
    Publication date: December 30, 2010
    Applicant: Immunex Corporation
    Inventors: Peter R. Baum, Sabine S. Escobar, Joanne L. Viney
  • BTL-II nucleic acids
    Patent number: 7709618
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: May 4, 2010
    Assignee: Immunex Corporation
    Inventors: Peter R Baum, Sabine S Escobar, Joanne L Viney
  • BTL-II NUCLEIC ACIDS
    Publication number: 20090142801
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Application
    Filed: June 8, 2007
    Publication date: June 4, 2009
    Applicant: IMMUNEX CORPORATION
    Inventors: Peter R. BAUM, Sabine S. ESCOBAR, Joanne L. VINEY
  • BTL-II proteins
    Patent number: 7244822
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: July 17, 2007
    Assignee: Immunex Corporation
    Inventors: Peter R. Baum, Sabine S. Escobar, Joanne L. Viney
  • BTL-II nucleic acids, proteins, and antibodies
    Publication number: 20040209289
    Abstract: The invention provides isolated BTL-II proteins, nucleic acids, antibodies, antagonists, and agonists and methods of making and using the same. Diagnostic, screening, and therapeutic methods using the compositions of the invention are provided. For example, the compositions of the invention can be used for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen.
    Type: Application
    Filed: December 19, 2003
    Publication date: October 21, 2004
    Inventors: Peter R. Baum, Sabine S. Escobar, Joanne L. Viney